3-[1-(acetyl)-4-piperidinyl]propionic acid | 131417-49-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 3-[1-(acetyl)-4-piperidinyl]propionic acid
• 英文别名: 3-(1-acetyl-4-piperidinyl)propanoic acid；3-(1-acetylpiperidin-4-yl)propionic acid；1-acetyl-4-piperidinepropionic acid；3-(1-Acetyl-4-piperidinyl)propionic acid；3-(1-Acetylpiperidin-4-yl)propanoic acid
• CAS: 131417-49-7
• 化学式: C₁₀H₁₇NO₃
• mdl: MFCD14706194
• 分子量: 199.25
• InChiKey: CBWPIRBWBJQAPM-UHFFFAOYSA-N

物化性质

• 沸点：
  397.5±15.0 °C(Predicted)
• 密度：
  1.122±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-[1-(acetyl)-4-piperidinyl]propionic acid 在 盐酸 作用下， 生成 3-(哌啶-4-基)丙酸盐酸盐
  参考文献：
  名称：

  EP1227090

  摘要：

  公开号：
• 作为产物：
  描述：

  3-哌啶-4-丙酸乙酯 在 氢氧化钾 作用下， 以 甲醇 为溶剂， 反应 2.0h， 生成 3-[1-(acetyl)-4-piperidinyl]propionic acid
  参考文献：
  名称：

  Central Cholinergic Agents. IV. Synthesis and Acetylcholinesterase Inhibitory Activities of .OMEGA.-(N-Ethyl-N-(phenylmethyl)amino)-1-phenyl-1-alkanones and Their Analogues with Partial Conformational Restriction.

  摘要：

  乙酰胆碱酯酶（AChE）抑制剂的设计是基于酶的活性位点的工作假设。这些化合物被测试了其对AChE的抑制活性，ω-[N-乙基-N-(苯甲基)氨基]-1-苯基-1-烷酮（3）被发现是有效的抑制剂。为了研究构象部分限制对AChE抑制的影响，制备了3的各种类似物。具有强效AChE抑制的化合物进一步评估了其中心选择性：中心作用（在T型迷宫交替任务中改善斯科波拉明诱导的记忆损害的效果）与外周作用的比率。

  DOI：

  10.1248/cpb.41.529

文献信息

• Thermogenic composition and benzazepine thermogenics
  申请人：Takeda Chemical Industries, Inc.

  公开号：US06534496B1

  公开（公告）日：2003-03-18

  The object of the present invention is to provide a prophylactic and/or therapeutic drug for obesity and obesity-associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the present invention is to provide a pharmaceutical composition comprising a compound of the following formula: wherein Ar represents phenyl which may be substituted and/or condensed; n represents an integer of 1 to 10; R represents hydrogen or a hydrocarbon group which may be substituted, which may not be the same in its n occurrences; R may be bound to either Ar or a substituent for Ar; Y represents an amino group which may be subsituted or a nitrogen-containing saturated heterocyclic group which may be substituted, or a salt thereof, which can be used for a thermogenic agent, an antiobesity agent, a lipolytic agent, or a prophylactic and/or treating drug for obesity-associated diseases.

  本发明的目的是提供一种用于肥胖和肥胖相关疾病或糖尿病的预防和/或治疗药物，其具有降低中枢副作用风险和高普遍性的特点。本发明的另一个目的是提供一种包含以下式的化合物的药物组合物： 其中Ar代表可能被取代和/或缩合的苯基；n代表1到10的整数；R代表氢或可能被取代的碳氢基团，在其n次出现时可能不相同；R可以与Ar或Ar的取代物结合；Y代表可能被取代的氨基或可能被取代的含氮饱和杂环基团，或其盐，可用作热原药剂、抗肥胖药剂、脂肪分解药剂，或肥胖相关疾病的预防和/或治疗药物。
• Synthesis and antibacterial activities of some novel 17, 18-unsaturated carbonyl compounds derivated from josamycin
  作者：Zhe-Hui Zhao、Long-Long Jin、Yan-Peng Xu、Chao Liu、A-Peng Wang、Ping-Sheng Lei

  DOI：10.1080/10286020.2016.1194834

  日期：2017.4.3

  Some novel josamycin derivatives bearing an arylalkyl-type side chain were designed and synthesized. By HWE or Wittig reaction, 16-aldehyde group of josamycin analogs were converted into unsaturated carbonyl compounds. They were evaluated for their in vitro antibacterial activities against a panel of respiratory pathogens. 8b and 8e exhibited comparable activities against a panel of respiratory pathogens

  设计并合成了一些带有芳烷基型侧链的新型久沙霉素衍生物。通过HWE或Wittig反应，将交沙霉素类似物的16-醛基转化为不饱和羰基化合物。评估了他们对一组呼吸道病原体的体外抗菌活性。图8b和图8e显示了针对一组呼吸道病原体的相当的活性，特别是对于一系列去霉菌糖基久他霉素类似物中的抗性病原体。在所有目标分子中，有21种显示出最佳的抗菌活性。
• Nitrogen-containing heterocyclic compound and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20090156572A1

  公开（公告）日：2009-06-18

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B is an aromatic ring optionally having substituent(s), ring C is a cyclic group optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group, a heterocyclic group optionally having substituent(s) or an amino group optionally having substituent(s), R 2 is an optionally halogenated C 1-6 alkyl group, m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof and the like. Since the compound has a superior tachykinin receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of various diseases such as lower urinary tract diseases, gastrointestinal diseases, central nervous system diseases and the like.

  本发明涉及一种由下式表示的化合物：其中环A是含氮杂环，可选择地进一步具有取代基，环B是芳香环，可选择地具有取代基，环C是环状基团，可选择地具有取代基，R1是氢原子，一个碳氢基团，可选择地具有取代基，酰基，一个杂环基团，可选择地具有取代基或一个氨基团，可选择地具有取代基，R2是可选择卤代的C1-6烷基基团，m和n分别是0到5的整数，m+n是2到5的整数，是单键或双键，或其盐等。由于该化合物具有优越的催吐肽受体拮抗作用，可用作预防或治疗多种疾病的药物，如下尿道疾病、胃肠道疾病、中枢神经系统疾病等。
• Condensed heterocyclic compounds, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05273974A1

  公开（公告）日：1993-12-28

  A condensed heterocyclic derivative of the formula (I): ##STR1## wherein X is an oxygen atom, a sulfur atom or R.sup.1 --N< wherein R.sup.1 is a hydrogen atom, a hydrocarbon group which may be substituted or an acyl group which may be substituted; R.sup.2 is a hydrogen atom or a hydrocarbon group which may be substituted; ring A is a benzene ring which may be substituted, k is a whole number of 0 to 3; m is a whole number of 1 to 8; and n is a whole number of 1 to 6, or a pharmaceutically acceptable salt thereof exhibiting high colinesterase inhibitory activity, and a method for producing the same.

  化学式（I）的一种缩合杂环衍生物：##STR1##其中X是氧原子、硫原子或R.sup.1--N<，其中R.sup.1是氢原子、可能被取代的碳氢基团或可能被取代的酰基团；R.sup.2是氢原子或可能被取代的碳氢基团；环A是可能被取代的苯环，k是0到3的整数；m是1到8的整数；n是1到6的整数，或其药学上可接受的盐，具有高胆碱酯酶抑制活性，并提供其制备方法。
• Tricyclic condensed heterocyclic compounds, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05527800A1

  公开（公告）日：1996-06-18

  A novel compound of the formula: ##STR1## wherein Ar represents an optionally substituted tricyclic condensed benzene ring group which includes at least one heterocyclic ring as a component ring; n represents an integer from 2 to 10; R.sup.1 represents H or an optionally substituted hydrocarbon group, which may be different from one another in the repetition of n; and Y represents an optionally substituted 4-piperidinyl, 1-piperazinyl or 4-benzyl-1-piperidinyl group, or a salt thereof, inhibiting excellent cholinesterase inhibitory activity and monoamine reuptake inhibitory activity, thus being useful as therapeutic and/or prophylactic medicaments of senile dementia.

  一种化合物的式子：##STR1## 其中Ar代表一个可选择取代的三环融合苯环基团，其中至少包含一个杂环环作为组成环；n代表一个从2到10的整数；R.sup.1代表H或一个可选择取代的烃基团，可能在n的重复中彼此不同；Y代表一个可选择取代的4-哌啶基、1-哌嗪基或4-苄基-1-哌啶基团，或其盐，抑制优异的胆碱酯酶抑制活性和单胺再摄取抑制活性，因此可用作治疗和/或预防老年性痴呆症的药物。